EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Dietary treatment of hyperlipoproteinaemia



Dietary treatment of hyperlipoproteinaemia



Wiener Medizinische Wochenschrift 140(4): 88...93



Hyperlipoproteinaemia is caused by exogenous factors (nutrition), and genetic factors (low density lipoprotein-receptor defects, apoprotein variants). Although a number of efficient lipid lowering drugs is now available, any therapy should start with a change of nutritional habits. Overweight needs to be decreased and special attention should be paid to fat modification, fat restriction and the decrease of cholesterol intake.

(PDF 0-2 workdays service: $29.90)

Accession: 002072151

Download citation: RISBibTeXText



Related references

Effects of dietary treatment on lipoprotein levels in hyperlipoproteinaemia. Postgraduate Medical Journal 51(8): Suppl 52-9, 1975

Coefficient of lipid clearance K2 in persons with type 4 hyperlipoproteinaemia before and after treatment of the hyperlipoproteinaemia with special diet. Nutrition and Metabolism 23(5): 416-428, 1979

Lipoprotein modifications during dietary treatment in patients with primary type V hyperlipoproteinaemia. European Journal of Clinical Investigation 16(2, I): 149-156, 1986

Lecithin: cholestrol acyl transfer rate and high density lipoproteins in plasma during dietary and cholestyramine treatment of type IIa hyperlipoproteinaemia. European Journal of Clinical Investigation 8(6): 383-389, 1978

Lecithin: cholesterol acyl transfer rate and high density lipoproteins in plasma during dietary and cholestyramine treatment of type Ila hyperlipoproteinaemia. European Journal of Clinical Investigation 8(6): 383-389, 1978

Hyperlipoproteinaemia in first-degree relatives of patients with primary hyperlipoproteinaemia. Deutsche Gesundheitswesen 37(39): 1690-1694, 1982

Hyperlipoproteinaemia and dietary fat modification in haemodialysis and renal transplant patients. Medical Journal of Australia 2(7): 207-208, 1977

Age and altered dietary habits influence hyperlipoproteinaemia after transplantation of the kidneys. Casopis Lekaru Ceskych 138(4): 111-115, 1999

High content of dietary linoleic acid does not reduce platelet reactivity in patients with hyperlipoproteinaemia. European Journal of Clinical Investigation 16(1): 28-34, 1986

Effects of omitting dietary sucrose and isoenergetic substitution of starch in primary type IV hyperlipoproteinaemia. Proceedings of the Nutrition Society 33(1): 2a-3a, 1974

Effects of dietary saturated and polyunsaturated fat on the metabolism of apolipoproteins A-I and B. Study of a patient with type IIb hyperlipoproteinaemia. Clinica Chimica Acta; International Journal of Clinical Chemistry 87(3): 395-404, 1978

High content of dietary linoleic acid does not reduce platelet reactivity in patients with hyperlipoproteinaemia. European Journal of Clinical Investigation 17(1): 92-92, 1987

Primary type V hyperlipoproteinaemia (mixed hyperlipaemia): successful response to dietary restriction and simfibrate. Singapore Medical Journal 15(2): 149-152, 1974

Acute effect of dietary therapy of Type IV hyperlipoproteinaemia on the serum and lipoprotein concentrations and relative composition. Atherosclerosis 30(1): 79-87, 1978

Conversion of type III hyperlipoproteinaemia to type IV hyperlipoproteinaemia by a fat-free, carbohydrate rich diet. European Journal of Clinical Investigation 5(4): 359-364, 1975